Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice.

BACKGROUND Acute renal failure (ARF) induced by sepsis has a high mortality. In an aged mouse model of sepsis-induced ARF we have previously shown that renal injury occurs before serum creatinine is elevated. Development of a noninvasive biomarker that could diagnose renal dysfunction early in sepsis and monitor the response to therapy would be very valuable. METHODS We performed magnetic resonance imaging (MRI) with gadolinium-based G4 dendrimer intravenous contrast in a fluid- and antibiotic-treated cecal ligation and puncture (CLP) sepsis model in aged mice. Imaging was also performed in a mouse volume depletion model and in models of ARF induced by ischemia/reperfusion (I/R) and cisplatin. RESULTS Twenty hours post-CLP, aged mice had a distinct pattern of renal injury using dendrimer-enhanced MRI. This pattern was different from renal injury induced by either cisplatin or I/R. Prerenal azotemia induced by volume depletion was distinguished from sepsis by dendrimer-enhanced MRI. Dendrimer-enhanced MRI detected renal dysfunction 6 hours post-CLP, a time when serum creatinine was still normal. Ethyl pyruvate reversed the renal dysfunction detected by dendrimer-enhanced MRI at 20 hours, but not at 6 hours post-CLP. The appearance of renal dysfunction on dendrimer-enhanced MRI at 6 hours post-CLP predicted the length of survival. CONCLUSION Dendrimer-enhanced MRI is a novel biomarker that provides information for the early diagnosis, drug responsiveness, and prognosis of sepsis-induced ARF.

[1]  R. Schrier.  Need to intervene in established acute renal failure. , 2004, Journal of the American Society of Nephrology : JASN.

[2]  Stephen M Hewitt,et al.  Discovery of protein biomarkers for renal diseases. , 2004, Journal of the American Society of Nephrology : JASN.

[3]  R. Star,et al.  A simplified method for HPLC determination of creatinine in mouse serum. , 2004, American journal of physiology. Renal physiology.

[4]  Hisataka Kobayashi,et al.  Micro-MRI methods to detect renal cysts in mice. , 2004, Kidney international.

[5]  K. Tracey,et al.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Bellomo,et al.  The pathogenesis of septic acute renal failure , 2003, Current opinion in critical care.

[7]  S. Hewitt,et al.  Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. , 2003, Kidney international.

[8]  P. Houillier,et al.  Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  J. Decruyenaere,et al.  Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. , 2003, Journal of the American Society of Nephrology : JASN.

[10]  J. Bonventre,et al.  Animal models of acute tubular necrosis , 2002, Current opinion in critical care.

[11]  R. Star,et al.  Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. , 2002, Kidney international.

[12]  K. Tracey,et al.  Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. le Gall,et al.  Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients* , 2002, Critical care medicine.

[14]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[15]  J. Bonventre,et al.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.

[16]  M. Brechbiel,et al.  Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent. , 2002, Kidney international.

[17]  S. Hewitt,et al.  Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. , 2001, Kidney international.

[18]  C. Sprung,et al.  Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score , 2000, Intensive Care Medicine.

[19]  C. Guérin,et al.  Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhône-Alpes Area Study Group on Acute Renal Failure. , 2000, American journal of respiratory and critical care medicine.

[20]  R. Hotchkiss,et al.  Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.

[21]  J Pascual,et al.  The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. , 1998, Kidney international. Supplement.

[22]  K E Hammermeister,et al.  Independent association between acute renal failure and mortality following cardiac surgery. , 1998, The American journal of medicine.

[23]  I. Housini,et al.  Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. , 1997, The Journal of clinical investigation.

[24]  C. Viscoli,et al.  The effect of acute renal failure on mortality. A cohort analysis. , 1996, JAMA.

[25]  Paul Landais,et al.  Acute renal failure in intensive care units : causes, outcome, and prognostic factors of hospital mortality : a prospective, multicenter study , 1996 .

[26]  P. Loirat,et al.  Acute renal failure in intensive care units--causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. , 1996, Critical care medicine.